In This Section

Home / State Society Education Series

State Society Education Series

SSES Workshops

This series supports education for allied health and cancer care professionals with the convenience of live and on-demand virtual learning opportunities. Tailored to the challenges surrounding the delivery of value-based, quality patient care, this program features national experts that represent the multiplidiscinary cancer care team. The State Society Education Series is a complimentary member benefit sponsored by eleven state societies.

Archived Webinars

Biosimilars: An Overview

Sandra Werking, PharmD, BCPS
Sandoz Pharmaceuticals

One complexity surrounding biosimilars lies in the essence of their variability. Join Sandy Werking, Sandoz Pharmaceuticals, as she explains the underpinnings of biologics. You’ll also get an overview of the FDA’s recently published draft guidelines for demonstrating biosimilar interchangeability and more!


Managing Your Patients’ Immune-Related Adverse Events (irAEs)

Brianna Hoffner, MSN, NP, RN
University of Colorado, School of Medicine

As the spectrum of immune-related adverse events (irAEs) expands to include less common, albeit more severe manifestations, early detection becomes increasingly vital for patient safety and treatment tolerability. If diagnosed quickly and managed properly, most irAEs are reversible. Watch this webinar to gain a deeper understanding of this growing spectrum and learn how to effectively manage your patients’ ieAEs using a multidisciplinary approach.


Creating Partnerships Between Oncology Nurse Navigators & Oncology Practices

Tricia Strusowski, RN, MS,
Oncology Solutions, LLC

Learn how cancer programs are successfully collaborating with nurse navigators to decrease admissions and emergency room visits, adhere to national guidelines, provide survivorship care plans, and deliver successful outcomes. The case studies presented in this webinar will demonstrate alignment with patient-centered, value-based models such as the Oncology Care Model (OCM) and more!


Adapting to USP <800> and What the Changes Will Mean for Oncology Practices

Willis Triplett, PharmD
Comply797 and Comply800


Steps to Success: Implementing Oral Oncolytics

Peter Schlickman, PharmD, BCOP
Sarah Cannon Research Institute

Oral agents offer benefits to both patients and providers. Because patients self-administer oral anticancer drugs at home, travel to treatment and time spent in the cancer center or physician office can be reduced. However, oral therapies present challenges in terms of patient compliance with treatment regimens, monitoring of side effects, and the cost of treatment.


How to Navigate Patient Financial Toxicity

Dan Sherman, MA, LPC
The NaVectis Group

Financial toxicity is one of the newest side effects of cancer care treatment for both patients and cancer programs. With a growing underinsured patient population and rising costs of care, the need to prepare patients for financial burdens is crucial. Benefit from the latest trends, effective practices, and strategies to better position your program to support patients as they deal with the financial issues surrounding cancer diagnosis and treatment.


Chemotherapy Safe Handling: What You Need to Know

Martha (Marty) Polovich, PhD, RN, AOCN
Georgia State University

Explore the requirements and recommendations for safe chemotherapy handling to establish your own chemotherapy program or ensure your existing program is being managed as safely as possible.


ICD-10 Accuracy and Denials: How to Document Properly

James Leach, MBS
E & M Consulting Inc.

Watch this webinar for tips on accurate billing and coding for ICD-10 and learn how ICD-10 can impact how your practice delivers quality patient care.


Biosimilars: Implications for Medical Oncology

George Silberman
The Cancer Policy Group, LLC

With the approval of the first biosimilar in March of 2015, questions regarding this new class of products—what they are, how they are regulated, how they are covered and reimbursement policies, and what implications they have for the quality and safety of care—have taken on a new urgency. This webinar addresses these questions from the perspective of medical oncology.


CMMI Oncology Care Model: Should You Participate and How to Prepare

Kavita Patel, MD, MS
Brookings Institution

In February of 2015, CMS announced a new payment model available to physician practices that administer chemotherapy. Watch this webinar to gain a strategic perspective on questions to consider before submitting your letter of intent.

Changes to ABIM’s Maintenance of Certification Program

Kevin Caviston
Strategic Communications at ABIM

Intended for physicians, this webinar will explain what Maintenance of Certification (MOC) is, why it is required, and how physicians can fulfill the requirements.


ICD-10 Check-In

James H. Leach, MBS
E&M Consulting, Inc.

It's the middle of 2014 and the timeline for ICD-10 has shifted again. Learn how to build on the work you've already done to prepare and strategies to help you make progress toward the new 2015 implementation date.


Financial Counseling Role-Play: Conversations with Patients and Caregivers

Catherine Credeur, LMSW, OSW-C
UT Southwestern Medical Center
John Hennessy
Sarah Cannon Cancer Center

This webinar focused on the financial counseling work we all do in our daily lives. The presenters introduced role-playing as a means of preparing for difficult financial conversations. The role-play scenarios provided in this program can be applied in daily practice to help with the financial challenges patients face.


New Strategies in Melanoma: Molecular Testing

Amit Jain, MD, MPH
Tallahassee Memorial Healthcare Hematology and Cancer Specialists
FSU College of Medicine

This presentation focused on the efficacy and use of molecular markers in the treatment of melanoma. This program was sponsored through a grant provided by Bristol-Myers Squibb.